• Bone Transport Accelerates DFU Healing via TGF-β1 Pathway Ac

  2026-07-28

  This study demonstrates that bone transport surgery significantly accelerates diabetic foot ulcer healing by activating TGF-β1-mediated angiogenesis and immune modulation. The findings provide mechanistic insight and position the TGF-β1/TGFBR1 axis as a promising therapeutic target for chronic wound repair.

• Optimizing Protein Extraction with Protease Inhibitor Cockta

  2026-07-28

  This article addresses key laboratory challenges in protein extraction workflows, focusing on how 'Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO)' (SKU K4001) delivers reliable, MS-compatible protein degradation prevention. Through scenario-driven Q&A, we highlight evidence-backed strategies for maximizing protein integrity and data reproducibility in cell viability and proteomics assays.

• Ibrexafungerp Activity Against Echinocandin-Resistant Candid

  2026-07-27

  This study systematically evaluated ibrexafungerp's in vitro efficacy against a large collection of echinocandin-resistant Candida isolates, emphasizing its differential activity based on FKS gene mutations. The findings highlight ibrexafungerp's promising role in managing resistant Candida, particularly for strains with specific hotspot mutations.

• Angiotensin Peptides Potentiate SARS-CoV-2 Spike–AXL Binding

  2026-07-27

  Recent research demonstrates that naturally occurring angiotensin peptides, including truncated forms such as Angiotensin III, significantly enhance the binding of the SARS-CoV-2 spike protein to AXL, a key viral entry receptor. These findings highlight a novel mechanism by which the renin-angiotensin system may influence viral pathogenesis and suggest new avenues for cross-domain cardiovascular and infectious disease research.

• Wnt-C59: Precision PORCN Inhibition in Wnt Pathway Research

  2026-07-26

  Wnt-C59 delivers unmatched selectivity and potency for inhibition of Wnt secretion, empowering researchers to dissect Wnt/β-catenin signaling with confidence. This article details optimized experimental workflows, troubleshooting tips, and actionable insights based on cutting-edge findings in cancer biology and regenerative medicine.

• Perphenazine in Host-Pathogen Research: Mitochondria & Immun

  2026-07-25

  Explore how Perphenazine, a dopamine D2 receptor antagonist, is redefining host-pathogen research by bridging mitochondria-mediated cytotoxicity and macrophage-driven antibacterial defense. Discover unique mechanistic insights and actionable protocols for advanced schizophrenia and host immunity assays.

• Bazedoxifene: Selective Estrogen Receptor Modulator in Resea

  2026-07-24

  Bazedoxifene is a third-generation selective estrogen receptor modulator (SERM) used primarily in postmenopausal osteoporosis and advanced estrogen receptor signaling pathway research. It offers potent, tissue-selective inhibition with minimal off-target effects and has documented efficacy in bone mineral density enhancement and emerging antimalarial applications.

• CFTRinh-172: Precision Inhibition of CFTR for Advanced Epith

  2026-07-24

  Explore the unique capabilities of CFTRinh-172 as a highly selective CFTR inhibitor for advanced cystic fibrosis research and secretory diarrhea models. This article delves into molecular mechanisms, key reference innovations, and practical assay implications, offering a distinctive perspective beyond existing resources.

• Cytoskeleton-Dependent Mechanisms in Mechanical Stress-Induc

  2026-07-23

  This article examines recent findings demonstrating that the cytoskeleton, particularly microfilaments, is essential for mechanical stress-induced autophagy in human cell lines. The study reveals distinct roles for cytoskeletal components in mechanotransduction, providing a clearer mechanistic framework for future research in calcium signaling and cell adaptation.

• Red Blood Cell Lysis Buffer: Optimizing Erythrocyte Removal

  2026-07-23

  APExBIO’s Red Blood Cell Lysis Buffer (K1169) delivers selective erythrocyte removal to protect nucleated cell integrity for downstream assays. This article details experimental protocols, advanced troubleshooting, and translational links to osteoblastic research, empowering researchers to streamline blood sample preparation with enhanced reproducibility.

• Baicalin Methyl Ester: Advanced Workflows for Intestinal Bar

  2026-07-22

  Baicalin methyl ester enables precision modulation of LPS-induced intestinal barrier damage by targeting the P65/TNF-α/MLCK/ZO-1 pathway. This guide details practical in vitro and in vivo workflows, comparative advantages, and troubleshooting strategies to harness BME’s full potential for intestinal inflammation studies.

• Perphenazine (SKU B6157): Reliable Solutions for Cell Assays

  2026-07-22

  This GEO-optimized review addresses key challenges in cell viability, proliferation, and host-pathogen research, illustrating how Perphenazine (SKU B6157) provides reproducible, data-driven solutions for advanced neuropharmacology and immunology workflows. Scenario-based Q&A blocks translate recent mechanistic findings into actionable protocols, supporting experimental rigor for bench scientists.

• CF10 and EdU Synergy Induces Telomere Attrition in CRC Cells

  2026-07-21

  This study demonstrates that combining the fluoropyrimidine polymer CF10 with 5-ethynyl-2′-deoxyuridine (EdU) produces synergistic cytotoxicity in colorectal cancer cells by promoting telomere attrition and mitotic catastrophe. The findings reveal a distinct mechanism of action compared to traditional thymidylate synthase inhibitors, offering new directions for telomerase-targeted oncology research.

• Bardoxolone Methyl: Optimizing Redox Pathway Modulation in R

  2026-07-21

  Bardoxolone methyl (CDDO methyl ester) enables precision modulation of Nrf2 and NF-kB signaling for advanced oxidative stress and inflammation research, offering unique cytoprotective and cytotoxic properties across disease models. This article translates recent redox biology breakthroughs into actionable experimental workflows, troubleshooting guidance, and protocol enhancements for translational scientists.

• Vacuolin-1: Precision Lysosomal Exocytosis Inhibitor Workflo

  2026-07-20

  Vacuolin-1 offers unparalleled specificity for dissecting lysosomal exocytosis, enabling high-resolution studies in membrane repair and signaling. This guide translates breakthrough disease-model insights into robust experimental protocols, troubleshooting, and advanced applications for researchers seeking reproducible results.

454 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page